Skip to main content

Table 1 Baseline demographics and clinical characteristics

From: The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy

Characteristic

Change analysis sample* (N = 535)

Excluded (N = 149)

Total sample (N = 684)

p-value†

Age (mean years, SD)

59.3 ± 10.8

59.3 ± 10.8

59.3 ± 10.8

0.97

Gender (n, %)

    

   Male

343 (64.1%)

90 (60.4%)

433 (63.3%)

0.44

   Female

192 (35.9%)

59 (39.6%)

251 (36.7%)

 

Ethnicity (n, %)

    

   Caucasian

438 (81.9%)

94 (63.1%)

532 (77.8%)

<0.0001

   African descent

42 (7.9%)

28 (18.8%)

70 (10.2%)

 

   East/Southeast Asian

21 (3.9%)

6 (4.0%)

27 (3.9%)

 

   Hispanic

17 (3.2%)

20 (13.4%)

37 (5.4%)

 

   Other

17 (3.2%)

1 (0.7%)

18 (2.6%)

 

Type of diabetes (n, %)

    

   Type 1

64 (12.0%)

16 (10.7%)

80 (11.7%)

0.77

   Type 2

471 (88.0%)

133 (89.3%)

604 (88.3%)

 

Duration of diabetes (years; mean ± SD)

16.3 ± 8.3

15.1 ± 7.5

16.0 ± 8.1

0.11

Body mass index (kg/m2; mean ± SD)

32.8 ± 6.9

32.8 ± 9.1

32.8 ± 7.4

0.95

ETDRS visual acuity rating (letters; mean ± SD)

    

   Best eye

81.3 ± 8.2

80.1 ± 8.6

81.1 ± 8.3

0.12

   Worst eye

72.2 ± 15.0

69.3 ± 17.2

71.6 ± 15.6

0.06

   Right eye

77.5 ± 12.2

75.6 ± 12.0

77.1 ± 12.2

0.08

   Left eye

76.0 ± 13.6

73.9 ± 16.8

75.6 ± 14.3

0.15

  1. *Patients with visual acuity assessment and at least one VFQ-25 subscale at both baseline and month 18
  2. †Continuous variables compared with t-tests; 2-level categorical variables such as gender compared with Fisher exact test; categorical variables with more than two levels compared with chi-square analyses
  3. ETDRS = Early Treatment Diabetic Retinopathy Study; SD = standard deviation; VFQ-25 = 25-Item Visual Function Questionnaire